[ Price : $8.95]
Baxter International files a BLA for OBI-1, a recombinant antihemophilic porcine sequence factor VIII for treating patients with a...[ Price : $8.95]
FDAs New Jersey District Office warns Ameriderm Laboratories about CGMP violations in its production of drug products.[ Price : $8.95]
FDA warns Sharplight Technologies about regulatory violations in its manufacturing of powered surgical laser instruments.[ Price : $8.95]
A joint FDA advisory committee votes to recommend approval for a Takeda Pharmaceutical BLA for vedolizumab and its use in treating...[ Price : $8.95]
FDAs Seattle District Office warns Jubilant HollisterStier about CGMP violations in its manufacturing of finished pharmaceuticals....[ Price : $8.95]
PhRMA calls on FDA to issue guidance on how drug companies can disseminate healthcare economic data under FDAMA Section 114 withou...[ Price : $8.95]
AbbVie reports positive data from its SAPPHIRE-II study of a three direct-acting-antiviral regimen plus ribavirin in patients with...[ Price : $8.95]
FDA approves a Zogenix supplemental NDA for a 4 mg dose of Sumavel DosePro Needle-free Delivery System.